Squamous Cell Carcinoma (mostly in transplant recipients) Update 2019

Dr. Sarah Aaron will review emerging research on squamous cell carcinoma (SCC) in transplant and non-transplant patients. She will also discuss how her studies of immunosuppressed patients have helped her treat the immunocompetent patient with SCC.

Presenter: Sarah Aaron, MD, PhD is a dermatologic surgeon who specializes in Mohs micrographic surgery. She is an Associate Professor of Dermatology and the Associate Director of Dermatologic Surgery and Laser Center at the University of California, San Francisco.

Special thanks to Ortho Dermatologics, Sanofi Regeneron, and AbbVie for their support and exhibition at this event.

Hidradenitis Suppurativa: a Few Steps Forward

Ginette A. Okoye MD, Professor and Chair of the Department of Dermatology at Howard University, walks us through her research on hidradenitis suppurativa, the pathogenesis of HS, and how studies contribute to our understanding and management of the disease. Dr. Okoye will also discuss how clinicians can incorporate research into their careers and share a few treatment pearls for HS.

Presenter: Ginette A. Okoye, MD is a Professor of Dermatology, Chair of the Department of Dermatology, at Howard University College of Medicine in Washington, DC.

Special thanks to Ortho Dermatologics, Sanofi and Regeneron for their support and exhibition at this event.

Deciphering the Relationship Between Cutaneous and Systemic Lupus Erythematosus

Dr. Benjamin Chong, Associate Professor of Dermatology in the Department of Dermatology at UT Southwestern Medical Center , sheds light (well hopefully not too much) on evidenced based expectations and management strategies for cutaneous lupus erythematosus.

Presenter:Benjamin Chong, M.D., is an Associate Professor in the Department of Dermatology at UT Southwestern Medical Center and holds the Anita C. Gilliam, M.D., Ph.D., Professorship in Dermatology. Dr. Chong is Director of the UT Southwestern Connective Tissue Disease Clinic and Medical Director of the Parkland Health and Hospital System Dermatology Clinic. He specializes in general dermatology and has expertise in cutaneous lupus erythematosus, dermatomyositis, and sarcoidosis.

Special thanks to Novartis for their support and exhibition at this event and to Pfizer for an unrestricted educational grant to support this program.

Translational Research in Vitiligo: Launching a new era of targeted treatment

John Harris, M.D., Assistant Professor in the Dermatology Division and Director of the Vitiligo Clinical Care and Research Center at UMMS explores emerging therapies in vitiligo.

Presenter: John Harris, M.D., Assistant Professor in the Dermatology Division and Director of the Vitiligo Clinical Care and Research Center at UMMS

Investigating Value in Everyday Dermatology

Hair, Hair, Everywhair: The Translational Journey to Elucidate the Role of JAK Inhibition in Alopecia Areata and Androgenic Alopecia

Approaches to Treating Advanced Melanoma

Time Heals All Wounds? Not Really: A Bench to Bedside Review on Cutaneous Wound Management

Robert Kirsner M.D., PhD, Professor and Harvey Blank Chair in Dermatology in the Department of Dermatology and Cutaneous Surgery at the University of Miami Miller School of Medicine challenges us with practical, translational pearls on wound care in this installment of the GW/JDD Translational Science Lecture Series. What is the best way to manage wound pain? Are scarless graft donor sites related to the easter bunny? What’s mo(i)st important for wound bandaging? Let’s be clear – ALL DERMATOLOGISTS SHOULD WATCH THIS.

Special thanks to Sun Pharma, for support of and exhibition at this event.

“I see Sezary cells:” Exploring the Molecular Basis of CTCL to Identify Better Treatments

Madeleine Duvic, M.D., Professor of Internal Medicine and Deputy Chairman of the Department of Dermatology at The University of Texas, MD Anderson Cancer Center in Houston, Texas, explores the molecular underpinnings of CTCL to highlight targets for established and emerging therapies.

Inante Immune Mechanisims – Translation to Novel Therapeutics For Skin Disease

Dr. Lloyd Miller, Associate Professor of Dermatology and Orthopedic Surgery at the Johns Hopkins School of Medicine, takes us on a translational tour of the innate immune response, highlighting specific aberrations in cutaneous pathology and drugable targets.

Special thanks to Novatis, Lilly, Allergan, Celgene, and Sanofi Regeneron, for support of and exhibition at this event.

Advances in Melanoma Risk Assessment and Metastatic Disease Monitoring

Dr. David Polsky, Professor of Dermatology and Pathology, Alfred W. Kopf, MD Professor of Dermatologic Oncology in the Department of Dermatology at NYU Langone Medical Center delivers a stelar presentation on both developing tools to better stratify risk factors for melanoma, and identifying novel biomarkers to allow for melanoma treatment efficacy monitoring and progress.

Special thanks to Genentech for support of and exhibition at this event.

Targeting cAMP Signaling for the Treatment of Inflammatory Diseases of the Skin

Dr. Jon Zippin, Assistant Attending Dermatologist and Assistant Professor of Dermatology at Weill Medical College of Cornell, elucidates the complexity of cAMP biology and the translational impact of PDE4 inhibition as it relates to chronic inflammatory skin diseases. Tune in to learn why targeting this pathway is clinically meaningful but also where more work is needed to improve outcomes.

Special thanks to Celgene and Pfizer for support of and exhibition at this event.